Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

A multi-center open study to determine the effect of lamivudine on HBV DNA clearance and to assess the safety of the regimen in patients with chronic hepatitis B infection.

Beata Bolewska, Jacek Adamek, Jacek Juszczyk, Andrzej Gładysz, Khalil Nazzal, Janusz Cianciara, Franciszek Król, Włodzimierz Mazur, Barbara Czajka, Katarzyna Swietek, Wiesław Kryczka, Zbigniew Gonciarz

Med Sci Monit 2002; 8(4): CR257-262 :: ID: 420871

Abstract

BACKGROUND: Patients with on-going HBV viral replication often presentwith clinical features of active chronic hepatitis. Until the recent introduction of nucleoside analogues,interferon-alpha was the only approved drug for these patients. One of the former drugs, lamivudine,has been shown in clinical trials in the US and Asia to effectively inhibit the viral polymerase of HBV.Our study was undertaken to assess the efficacy and safety of lamivudine therapy in Polish patients withchronic hepatitis B. MATERIAL/METHODS: Forty-five patients with chronic hepatitis B (HBeAg positive,anti-e negative, HBV-DNA positive by hybridization assay) were enrolled in the study. The patients received100mg of lamivudine orally, once daily for 12 months. They returned for routine clinical and laboratorycontrol every two weeks during the first months of treatment, and later at 3-month intervals while receivinglamivudine. RESULTS: At the end of treatment, serum HBeAg was not detected in 21 patients (48.8%), andanti-HBe appeared in the serum of 19 patients. 37.2% of the patients in the study group showed sustainedsuppression of serum HBV DNA at the end of treatment. Lamivudine therapy was well tolerated, with therate of occurrence of adverse events similar to that observed in other clinical studies. CONCLUSIONS:12-month lamivudine therapy in this Polish population of patients with chronic hepatitis B induced ahigh rate of HBeAg seroconversion, accompanied by reduction of HBV-DNA and the normalization of alanineaminotransferase activities.

Keywords: Abdominal Pain, Alanine Transaminase, Angina Pectoris, Antiviral Agents, Biological Markers, bronchopneumonia, Colitis, Ulcerative, DNA, Viral, Gastrointestinal Diseases, Hepatitis B Antibodies, Hepatitis B e Antigens, Hepatitis B virus, Hepatitis B, Chronic, Lamivudine, Poland, Reverse Transcriptase Inhibitors, Safety, Urinary Tract Infections, Viral Load, Viremia, Virus Replication

Comments

Editorial

01 January 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Patients

Dinah V. Parums
Science Editor, Medical Science Monitor, International Scientific Information, Inc., Melville, NY, USA

DOI: 10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

SARS-CoV-2/COVID-19

25 January 2022 : Editorial  

Editorial: The 2022 World Health Organization (WHO) Priority Recommendations and Response to the Omicron Va...

Med Sci Monit In Press; DOI: 10.12659/MSM.936199  

25 January 2022 : Clinical Research  

Experience of the Polish Medical Air Rescue Service During the First Year of the COVID-19 Pandemic and Meas...

Med Sci Monit In Press; DOI: 10.12659/MSM.935474  

11 January 2022 : Clinical Research  

A Remote Questionnaire-Based Study to Compare Alcohol Use in 1030 Final-Year High School Students in Split-...

Med Sci Monit In Press; DOI: 10.12659/MSM.935567  

31 December 2021 : Clinical Research  

A Prospective Observational Study of 42 Patients with COVID-19 infection and a History of Hepatitis C Virus...

Med Sci Monit 2021; 27:e935075

In Press

27 Jan 2022 : Clinical Research  

Retrospective Study of the Association Between Platelet-to-Lymphocyte Ratio in Patients with Acute Coronary...

Med Sci Monit In Press; DOI: 10.12659/MSM.935002  

25 Jan 2022 : Editorial  

Editorial: The 2022 World Health Organization (WHO) Priority Recommendations and Response to the Omicron Va...

Med Sci Monit In Press; DOI: 10.12659/MSM.936199  

25 Jan 2022 : Clinical Research  

Experience of the Polish Medical Air Rescue Service During the First Year of the COVID-19 Pandemic and Meas...

Med Sci Monit In Press; DOI: 10.12659/MSM.935474  

24 Jan 2022 : Clinical Research  

Causes of Lower Respiratory Tract Infections and the Use of Diagnostic Biomarkers in Blood Samples from Chi...

Med Sci Monit In Press; DOI: 10.12659/MSM.934889  

Most Viewed Current Articles

30 Dec 2021 : Clinical Research  

Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...

DOI :10.12659/MSM.935379

Med Sci Monit 2021; 27:e935379

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

01 Nov 2020 : Review article  

Long-Term Respiratory and Neurological Sequelae of COVID-19

DOI :10.12659/MSM.928996

Med Sci Monit 2020; 26:e928996

05 Mar 2020 : Clinical Research  

The Effects of Social Support on Sleep Quality of Medical Staff Treating Patients with Coronavirus Disease ...

DOI :10.12659/MSM.923549

Med Sci Monit 2020; 26:e923549

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750